| HDP‑expressing cells | Antibacterial effects | Immunomodulatory effects | Advantages | Limitations | Ref |
---|---|---|---|---|---|---|
LL-37 | · Macrophages · Neutrophils · NK cells · Mast cells · Monocytes · lymphocytes · Epithelial cells | · Disrupt bacterial walls/membranes (The models of membrane disruption proposed include aggregate, toroidal, barrel-stave, and carpet models) · Inhibit internal targets (such as protein synthesis, DNA/RNA synthesis, translation, and protein folding) | · Recruit immunocytes (such as neutrophils, eosinophils, monocytes, and T cells) · Induce apoptosis in some cell types (such as epithelial cells and regulatory T cells) and inhibit neutrophil apoptosis · Induce Mast cell degranulation to enhance diapedesis · Inhibit proinflammatory responses selectively · Induce M1 macrophage switch and upregulate phagocytosis · Facilitate angiogenesis and wound healing · Induce cytokine and chemokine production (such as CXCL8, and CCL7) · Adjuvant effects | · Powerful and broad-range immunomodulator functions · Inflammation suppressive effects · Prohealing effects · Synergistic interaction with antibacterial agents · Pro-osteogenic effects described · Anti-biofilm/Antifungal/Antiviral activity | · Weak direct antibacterial effects · Limited preclinical evidence for IAI prevention · High cost of production · Limited stability in vivo · Limited tissue penetration | |
Defensins | · Macrophages · Neutrophils · NK cells · Mast cells · Monocytes · DCs | · Disrupt bacterial walls/membranes (The models of membrane disruption proposed include aggregate, toroidal, barrel-stave, and carpet models) · Inhibit internal targets (such as protein synthesis, DNA/RNA synthesis, translation, and protein folding) | · Recruit immunocytes (such as neutrophils, eosinophils, monocytes, and T cells) · Induce cytokine and chemokine production (such as CXCL8, IL-6, CCL2, and GM-CSF) · Induce apoptosis in some cell types and inhibit neutrophil apoptosis · Promote or inhibit inflammatory · Promote or inhibit angiogenesis; promote wound healing · Maintain gut homeostasis · Form nanonets · Adjuvant effects | · Powerful and broad-range immunomodulator functions · Prohealing/angiogenic effects · Synergistic interaction with antibacterial agents · Antifungal/Antiviral activity · Each type of defensins has a unique role in innate immunity | · Weak direct antibacterial effects · Induce undesirable proinflammatory processes around the biomaterial. · Unpredictable off-target effects · Limited preclinical evidence for IAI prevention · High cost of production · Limited stability in vivo · Limited tissue penetration |